Beta-adrenergic blocking agents in cutaneous and oral melanoma
Beta-adrenergic blocking agents, or beta-blockers, are primarily used to manage cardiovascular conditions such as hypertension, heart failure, and arrhythmias by blocking the effects of stress hormones on beta-adrenergic receptors, reducing heart rate and blood pressure. Recent research highlights t...
Saved in:
Main Author: | Sivakamavalli Jeyachandran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003704 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024-11-01) -
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01) -
Scrutinizing the evidence of anthracene toxicity on adrenergic receptor beta-2 and its bioremediation by fungal manganese peroxidase via in silico approaches
by: Muhammad Naveed, et al.
Published: (2025-01-01) -
Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
by: Jee Soo Park, et al.
Published: (2025-01-01) -
Vitiligo and cutaneous malignancy: what is the risk?
by: Sahngeun Jenny Mun, et al.
Published: (2024-12-01)